IUBio Biosequences .. Software .. Molbio soft .. Network News .. FTP

Call for papers on GAL4/UAS Fly Strains

Kevin Cook kcook at bio.indiana.edu
Wed Feb 13 16:02:17 EST 2002

genesis:The Journal of Genetics and Development

Special Issue: GAL4/UAS Fly Strains

The entire August 2002 issue of genesis (www.wiley.com/genesis) will 
contain a series of peer-reviewed papers documenting fly strains with Gal4 
or UAS genes.  The editors in consultation with the Bloomington Drosophila 
Stock Center have decided to do this for several reasons.  The special 
issue will provide a mechanism for laboratories to publish their fly 
strains well before reporting the outcomes of long-term experiments.  In 
addition, the issue will provide readers with thorough documentation of 
important genetic reagents that will be centrally accessible through 
FlyBase.  Our experience with previous special issues (February 2000 and 
2002) suggests that this Special GAL4/UAS Fly Strain Issue of genesis will 
facilitate conditional genetic research in the fly community.

Author Instructions
The manuscript should be written in the style of a correspondence with no 
abstract or sections.  The discussion should be minimal.  The length will 
be a maximum of 2000 words excluding references.  Methods will be detailed 
but succinct and can be placed in figure legends. References should not be 

GAL4 lines
Provide detailed information about the engineered construct or enhancer 
trap used to generate the line.  GAL4 driven expression must be documented 
using a visible cellular marker, for example UAS-lacZ, etc.  GAL4 driven 
expression must be documented during embryogenesis, in the 3rd instar 
larvae, and the adult ovary and testis. GAL4 lines should be assessed using 
a deleterious UAS line (e.g. UAS-ricin/DTA) to determine stage of lethality.

UAS lines
Provide detailed information about the engineered construct or enhancer 
trap used to generate the line.  Experimental evidence of GAL4 driven 
expression must be documented which may include: rescue of loss-of-function 
phenotype, ectopic expression phenotype, or molecular evidence of expression.

Other information
Provide genetic background for each line.  Minimally, the author should 
provide the identity of the chromosome bearing the insertion.  However, 
more precise mapping is recommended.  Phenotypes caused by the insertions 
should be described.

Nomenclature of constructs and insertions should conform to
standard FlyBase nomenclature. Nomenclature guidelines are described in
detail at 

Reference formats can be obtained through the genesis website at 

There will be one page of free color.

Submit 1 original and 2 copies of the manuscript plus artwork to either:

Terry Magnuson
Department of Genetics
CB #7264, Lineberger Cancer Center
UNC-Chapel Hill
102 Mason Farm Road
Chapel Hill, NC 27599-7264
Office Tel: 919-843-6475
Lab: 919-843-6474 or 6473
E-mail: trm4 at med.unc.edu

Richard Behringer
Department of Molecular Genetics
University of Texas
M. D. Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
Tel: (713) 794-4618
Email: rrb at notes.mdacc.tmc.edu



More information about the Dros mailing list

Send comments to us at biosci-help [At] net.bio.net